Karl Hecker, Tony Galindo, Agilent, Thermo Electron, BD, GeneOhm, Proteomics Research, Beckman, Expression Pathology, Ciphergen | GenomeWeb

People

Karl Hecker has joined PerkinElmer as director of research and development for its Boston-based center of excellence, the firm said this week. Hecker joins PerkinElmer from Invitrogen.

He will be responsible for leading all product R&D efforts for molecular medicine within the company's life and analytical sciences unit. Hecker holds a PhD in biochemistry from Florida State University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.